Literature DB >> 16220406

IMRT with compensators for head-and-neck cancers treatment technique, dosimetric accuracy, and practical experiences.

Henning Salz1, Tilo Wiezorek, Marcel Scheithauer, Michael Schwedas, Jochen Beck, Thomas Georg Wendt.   

Abstract

BACKGROUND AND
PURPOSE: With three-dimensional conformal intensity-modulated radiotherapy (3D-c-IMRT) a heterogeneous dose distribution can be achieved in both planning treatment volume and in adjacent normal tissues and organs to be spared. 3D-c-IMRT demands for modified photon fluence profiles which can be accomplished with different techniques. This report deals with the commissioning of metal compensators and the first experiences in clinical use. Dosimetric accuracy, dose coverage and practical experience like treatment delivery time, monitor units and dose outside the treated volume are evaluated. PATIENTS AND METHODS: From January 2002 to April 2004, 24 patients with head-and-neck cancers were treated with 3D-c-IMRT using tin-wax compensators. The dose prescription included a simultaneously integrated boost (SIB). High-dose volume was irradiated with 60-70 Gy (median 66 Gy), low-dose volume with 48-54 Gy (median 52 Gy) administered by a standardized seven- portal coplanar beam arrangement. Dose at one parotid gland was aimed at 26 Gy. The compensators used consisted of tin granules embedded in wax; recalculation was performed with compensators made of the alloy MCP96 as well.
RESULTS: In 21 of 24 patients 3D-c-IMRT with tin-wax compensators reduced the median dose to one parotid gland to < 30 Gy. Recalculation with compensators with higher density which allowed higher attenuation revealed better protection of the parotid gland. The treatment delivery time per fraction was between 6 and 12 min (plus time for patient positioning), approximately 300 MU per 2 Gy were applied. The dose outside the treated volume was increased with regard to open fields and comparable with a physical wedge of 15-30 degrees . Quality assurance and treatment of patient were fast and simple. It was shown, that calculated dose distribution corresponded to measured dose distribution with high accuracy.
CONCLUSION: The described method offers facilities for a good dose coverage of irregular target volumes with different prescribed doses and a considerable dose reduction in adjacent organs at risk. The dose sparing of organs at risk can be further improved, if a compensator material with higher density is used.

Entities:  

Mesh:

Year:  2005        PMID: 16220406     DOI: 10.1007/s00066-005-1402-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  6 in total

1.  Comparative analysis of SmartArc-based dual arc volumetric-modulated arc radiotherapy (VMAT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Hui-Min Ting; Su-Hua Lo; Yu-Wen Wang; Chiu-Ching Tuan; Fu-Min Fang; Te-Jen Su
Journal:  J Appl Clin Med Phys       Date:  2011-11-15       Impact factor: 2.102

2.  Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.

Authors:  Evangelia Peponi; Christoph Glanzmann; Guntram Kunz; Christoph Renner; Katja Tomuschat; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

3.  Dosimetric verification of compensated beams using radiographic film.

Authors:  Slaven Jurkovic; Gordana Zauhar; Dario Faj; Deni Smilovic Radojcic; Manda Svabic; Mladen Kasabasic; Ana Diklic
Journal:  Radiol Oncol       Date:  2011-07-20       Impact factor: 2.991

4.  3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.

Authors:  Thomas G Wendt; Nasrin Abbasi-Senger; Henning Salz; Ines Pinquart; Sven Koscielny; Susi-Marie Przetak; Tilo Wiezorek
Journal:  Radiat Oncol       Date:  2006-06-21       Impact factor: 3.481

5.  Effect of dental metal artifact conversion volume on dose distribution in head-and-neck volumetric-modulated arc therapy.

Authors:  Kenta Kitagawa; Hitoshi Ikushima; Motoharu Sasaki; Shunsuke Furutani; Takashi Kawanaka; Akiko Kubo; Chisato Tonoiso; Takaharu Kudoh; Yosuke Kano; Akira Tsuzuki
Journal:  J Appl Clin Med Phys       Date:  2020-11-23       Impact factor: 2.102

6.  Prospective matched study on comparison of volumetric-modulated arc therapy and intensity-modulated radiotherapy for nasopharyngeal carcinoma: dosimetry, delivery efficiency and outcomes.

Authors:  Bin-Bin Chen; Shao-Min Huang; Wei-Wei Xiao; Wen-Zhao Sun; Ming-Zhu Liu; Tai-Xiang Lu; Xiao-Wu Deng; Fei Han
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.